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Abstract: Annotated formalin-ﬁxed, parafﬁn-embedded
(FFPE) tissue archives constitute a valuable resource for
retrospective biomarker discovery. However, proteomic
exploration of archival tissue is impeded by extensive
formalin-induced covalent cross-linking. Robust method-
ology enabling proteomic proﬁling of archival resources
is urgently needed. Recent work is beginning to support
the feasibility of biomarker discovery in archival tissues,
but further developments in extraction methods which are
compatible with quantitative approaches are urgently
needed. We report a cost-effective extraction methodol-
ogy permitting quantitative proteomic analyses of small
amounts of FFPE tissue for biomarker investigation. This
surfactant/heat-based approach results in effective and
reproducible protein extraction in FFPE tissue blocks. In
combination with a liquid chromatography-mass spec-
trometry-based label-free quantitative proteomics meth-
odology, the protocol enables the robust representative
and quantitative analyses of the archival proteome.
Preliminary validation studies in renal cancer tissues have
identiﬁed typically 250-300 proteins per 500 ng of tissue
with 1D LC-MS/MS with comparable extraction in FFPE
and fresh frozen tissue blocks and preservation of tumor/
normal differential expression patterns (205 proteins, r )
0.682; p < 10-15). The initial methodology presented here
provides a quantitative approach for assessing the po-
tential suitability of the vast FFPE tissue archives as an
alternate resource for biomarker discovery and will allow
exploration of methods to increase depth of coverage and
investigate the impact of preanalytical factors.
Keywords: Formalin-ﬁxed parafﬁn-embedded (FFPE) tis-
sue • proteomics • label-free quantitation • renal cell
carcinoma • tissue biomarkers • biomarker discovery •
archival tissue
Introduction
Acquiring fresh tissue biopsies requisite for the discovery/
validation phases of biomarker investigation is challenging,
particularly for rarer diseases.
1,2 Formalin-ﬁxed, parafﬁn-
embedded (FFPE) tissue archives represent a valuable alternate
resource. Signiﬁcant efforts are now being made to overcome
the effects of formalin cross-linkage on protein analysis.
3-10
While most studies are Western blot, reverse-phase array or
surface enhanced laser desorption ionization-time-of-ﬂight
(SELDI-TOF)-based,
7,11-13 recently developed mass spectrom-
etry-compatible extraction methods have expanded our ability
to proﬁle the archival proteome.
6,9,10,14-17
Studies exploring extracted archival proteins using high-
throughput shotgun proteomics methodologies are few, due
to incompatibility of the detergent buffer components which
are needed for effective solubilization with mass spectrom-
etry.
8,10,15,18,19 The current leader methodology uses a com-
mercially available buffer (Liquid Tissue buffer (LTB), Ex-
pression Pathology) to successfully extract proteins from
FFPE tissues.
6,17,18 Using LTB, comparable protein numbers
have been reported for matched frozen and FFPE (168 and
143 proteins. respectively. using 1D-LC-MS) in renal tissue
extracts, with 68% overlap between the two groups. Using a
relative quantitative approach of normalized spectral count-
ing, grade-dependent correlations with glycolytic and amino
acid synthetic pathways in renal cell carcinoma were de-
scribed.
17 Similar extraction efﬁciencies and subcellular
representations have also been achieved using LTB in frozen
versus FFPE rat liver tissues.
15 However, patent restrictions
on the LTB constituents restrict the necessary further
protocol reﬁnement required at the early phase of method
development. Furthermore, its high cost limits the wide-
spread use of the buffer, particularly for large-scale bio-
marker applications. An alternative approach combining
ammonium bicarbonate buffer, sonication, and heating to
analyze colon adenoma tissues resulted in the identiﬁcation
of almost 400 proteins by direct LC-MS/MS, comparable to
data from our study. A second experiment using a combined
peptide isoelectric focusing (IEF) and reverse phase LC-MS/
MS approach identiﬁed over 2000 proteins with an overlap
of 67%.
8 The higher number of protein identities achieved
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separation of peptides into 20 initial fractions is impressive,
but implementing this degree of fractionation has implica-
tions for both quantitation and application to the large
cohorts typically encountered in biomarker investigation due
to the analysis time involved. The study additionally exam-
ined the effect of preanalytic variables (ﬁxation times, storage
duration) on protein extraction in FFPE tissues. These initial
studies highlight the potential utility of the application of
high-throughput MS techniques to FFPE tissue. However,
further protocol reﬁnements and standardization are needed
to objectively evaluate the extraction methodologies and the
suitability of the archival resources for biomarker investiga-
tion, particularly innovations permitting quantitative com-
parisons.
20-22
The efﬁcacy of sodium dodecyl sulfate (SDS) in early heat-
induced antigen retrieval (HIAR) protocols for the reversal of
formalin-induced cross-links and subsequent recognition of
proteins by antibodies in immunohistochemistry is attributable
to its dual role of detergent and denaturant.
23 However,
interference with trypsin digestion, incompatibility due to ion
suppression, and adduct formation have necessitated SDS
cleanup steps prior to mass spectrometric (MS) analysis,
resulting in lower throughput and unpredictable protein losses,
with implications for downstream detection and quantitation.
MS-compatible surfactants offer a viable alternative. Of par-
ticular interest is an acid-labile surfactant developed by Waters
Corporation as a substitute for SDS in polyacrylamide gel
electrophoresis. The analogue, sodium 3-[(2-methyl-2-undecyl-
1,3-dioxolan-4-yl)methoxy]-1-propanesulfonate (RapiGest SF)
has detergent, denaturant, and electrophoretic properties
comparable to SDS and actually enhances trypsin digestion.
24
The acid-labile character of the detergent results in its degrada-
tion on acidiﬁcation, permitting direct MS analysis without
further sample processing resulting in minimal sample loss or
introduced bias for quantitiative measurements. Furthermore,
it increases the solubility and proteolytic cleavage of hydro-
phobic proteins, increasing peptide recovery.
In this study, we report a novel, robust, cost-effective
approach using a RapiGest extraction buffer to investigate the
archival proteome in a robust and high-throughput manner.
The workﬂow is coupled to an LC-MS based label-free
quantitative approach (Waters Corporation, Manchester,
U.K.)
25,26 to achieve reproducible, representative quantitation
of archival tissue proteins from FFPE blocks. In this work, we
apply multiple LC-MS quantitative strategies to the analysis
of extracted FFPE tissues to assess parameters including;
extraction efﬁciency, depth of coverage, and analytical repro-
ducibility. The resulting extraction and quantitative methodol-
ogy will facilitate further detailed objective assessment of the
suitability of formalin-ﬁxed archival tissue as an alternate
resource for novel biomarker discovery and validation.
Experimental Procedure
Materials. General chemicals were purchased from Sigma
(Poole, U.K.), VWR (Leicester, U.K.), and MP Biomedicals
(London, U.K.). Complete mini protease inhibitor tablets were
purchased from (Roche, U.K.); RapiGest SF from Waters
Corporation, U,K,; and the Micro BCA Protein Quantitation Kit
from Pierce. Modiﬁed sequencing grade trypsin was obtained
from Promega and all HPLC-grade solvents for mass spectrom-
etry, for example, formic acid and acetonitrile were from Merck
(U.K.).
Tissue Samples. Informed consent was obtained from all
patients and the research was reviewed and approved by the
local research ethics committee. Tissue blocks (∼125 mm3)
from patients undergoing nephrectomy were placed in 10 mL
of ice-cold RPMI buffer containing a Complete mini protease
inhibitor tablet, embedded in OCT compound, and frozen in
liquid nitrogen. In parallel, the nephrectomy specimens were
ﬁxed in formalin by the hospital Pathology Department for
routine diagnostic use. For the latter, tissue blocks were ﬁxed
overnight in 10% (v/v) neutral buffered formaldehyde, dehy-
drated in graded ethanol, permeated in xylene, parafﬁn-
embedded, and stored at room temperature.
The preliminary workup experiments were carried out on
frozen and formalin-ﬁxed matched normal renal cortex and
renal cell carcinoma (RCC) tissue samples from a total of 5
patients undergoing nephrectomy (R330N/T, R320N/T, R319N/
T, R316N, R318N) with grade 3 or 4, and TNM stages II or III
clear cell RCC. Matched frozen and FFPE tumor and normal
renal cortex from two patient samples (R320 for 1D analysis,
and R330 for 2D analysis) were taken forward for more stringent
label-free quantitation studies and technical replicate analyses.
Sections from all tissue blocks were histologically reviewed by
a Consultant Pathologist (P.H.). All samples used in the study
had been stored for between 6-24 months to minimize pos-
sible variation introduced by long-term storage.
Method Development Overview. In the early protocol
optimization phase, extraction solutions including RapiGest
buffer (0.2% (w/v) RapiGest, 5 mM dithiothreitol (DTT) in 50
mM NH4HCO3), modiﬁed RIPA buffer (pH 7.0),
11 30% v/v
acetonitrile (ACN) in 100 mM NH4HCO3,
3,4 and SDS extraction
buffer
7 were compared and assessed in terms of protein
extraction and compatibility with LC-MS analysis. Brieﬂy, three
serial FFPE tissue sections of 10 µm thickness (each ∼5 × 5
mm area) were deparafﬁnized and rehydrated as described
below, and extracted with the different buffers, using an
extended temperature protocol (105 °C for 30 min, 80 °C for
2 h). Extracts were reduced, alkylated, and trypsin digested as
detailed below. Initial experiments examining extraction ef-
ﬁciency and technical reproducibility were carried out using a
Q-STAR mass spectrometer (ABI, Foster City, CA) by assessing
the number of proteins identiﬁed and amino acid sequence
coverage. The resulting optimized RapiGest extraction protocol
was subsequently selected as the method to pursue. The
optimized workﬂow for the extraction and quantitation of
proteins from archival tissue blocks is described further below
and summarized in Figure 1. The compatibility with down-
stream quantiﬁcation was assessed using label-free LC-MS
quantitation methodology with analysis on a Synapt HDMS
quadrupole-oa-TOF (Waters Corporation, U.K.) and using
matched frozen and FFPE tissues. To deﬁne technical repro-
ducibility of the extraction methodology, four independently
extracted lysates from a normal renal FFPE tissue block were
each assessed using triplicate replicate injections by LC-MS.
A further comparative experiment used online multidimen-
sional chromatographic separations prior to MS analysis to
evaluate the depth of proteome coverage in extracts from
matched frozen and FFPE samples.
Protein Extraction from Fresh Frozen Tissue Samples.
Three serial sections of 10 µm thickness (each ∼5 × 5 mm area)
of fresh normal renal or RCC tissue (blocks were trimmed of
surrounding OCT prior to sectioning) were collected into an
Eppendorf tube. Flanking 5 µm sections on slides were rou-
tinely stained with hematoxylin and eosin (H&E) to verify tissue
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ammonium bicarbonate was added to each tube prior to
heating at 100 °C for 5 min. Samples were cooled for 5 min on
ice.
Protein Extraction from FFPE Tissue Blocks. Three serial
sections of 10 µm thickness (each ∼5 × 5 mm area) from FFPE
tissue blocks were collected in Eppendorf tubes. Samples were
deparafﬁnized by washing tissue slices in 1 mL of xylene (2 ×
1 min) followed by rehydration in a graded ethanol series (1
mL of 100%, 90% (v/v), 70% (v/v), 1 min each). The supernatant
was discarded after each wash and the tissues were microcen-
trifuged at the end of the washes to remove excess ethanol. A
total of 100 µL of 0.2% (w/v) RapiGest in 50 mM ammonium
bicarbonate and 5 mM DTT was added and tubes were sealed
with plastic clips (Qiagen, Germany) prior to heating at 105 °C
for 30 min. The samples were cooled for 5 min on ice, vortexed
vigorously, and heated at 80 °C for a further 2 h before cooling
on ice for 5 min.
Reduction, Alkylation, and Trypsin Digestion of Frozen
and FFPE Protein Extracts. A1 0µL aliquot of the protein
extract was removed for the estimation of protein concentra-
tion. Samples were reduced in 5 mM dithioerythritol (DTE) for
30 min on a 60 °C heating block followed by alkylation with
incubation in 15 mM iodoacetamide for a further 30 min in
the dark at room temperature. Modiﬁed sequencing grade
trypsin (16000 U/mg, Promega, U.K.) reconstituted in 50 mM
ammonium bicarbonate was added to the extract at an
enzyme/substrate ratio of 1:50 (w/w), and incubated overnight
at 37 °C.
Postdigestion Protocol. To facilitate the hydrolysis of the
RapiGest detergent for compatibility with mass spectrometry,
the samples were acidiﬁed in 0.5% (v/v) triﬂuoroacetic acid
(TFA) and incubated at 37 °C for 30 min. Samples were
microfuged for 15 min at 12 000g to remove the insoluble white
precipitate and any cellular debris, with the supernatant dried
in a SpeedVac (Thermo Electron, U.K.) and stored at -20 °C
until used. Estimation of protein concentrations was carried
out using a microBCA protein quantitation kit (Pierce) accord-
ing to the manufacturer’s instructions with 0.2% (w/v) RapiGest
in 50 mM ammonium bicarbonate as the diluent and albumin
for the construction of standard curves. Tissue extracts were
required to be diluted 5-fold in the RapiGest diluent to prevent
any interference with the assay from residual DTE.
SELDI-TOF Analysis. A SELDI-TOF instrument was used in
preliminary optimization experiments to allow the rapid com-
parison of extraction and digestion efﬁciencies of different
buffers with fresh and formalin-ﬁxed renal tissue. Digests from
frozen and FFPE extractions were resuspended in 5% (v/v)
ACN/0.05% TFA and 1 µg of protein extract was spotted on to
a NP20 chip (Ciphergen Biosystems, Inc.). After drying, spots
were overlaid with 2 µL of freshly prepared matrix (saturated
sinapinic acid in 50% (v/v) ACN/0.05% (v/v) TFA) for acquisi-
tion of spectra. Chips were analyzed using a PBS-II SELDI-TOF
(Ciphergen, Freemont, CA) using protocols with low and high
mass acquisition of 500 Da-25 000 kDa, optimized center of
2.5-6.5 kDa, laser intensity of 175-195, and detector sensitivity
of 9, collecting 50 transients per spot.
1D LC/MS/MS and 2D LC/MS/MS Qualitative Analyses. For
1D LC/MS/MS analyses, the tryptic digests from FFPE and
frozen tissue extracts were analyzed using an Agilent 1100 series
nano-LC system coupled online to an Applied Biosystems
QSTAR XL quadrupole TOF hybrid mass spectrometer. Mobile
phases were 0.1% (v/v) formic acid (A) and ACN, 0.1% (v/v)
formic acid (B). Samples (1.0 µg) were loaded at a 20 µL/min
ﬂow rate into a trap column (5 mm ×0.3 mm i.d., 5 µm particle
size, Zorbax 300SB C18, Agilent Technologies) in eluent A. The
trap column was switched in-line with the analytical column
(150 mm ×75 µm i.d., 5 µm particle size, Vydac 218MS5.07515,
Grace) and the peptides were separated on an 8-38% linear
gradient of eluent B over 45 min, with a 200 nL/min ﬂow rate.
The eluate was ionized and subjected to data-dependent mass
spectrometry: an MS scan of 400-1800 m/z was performed for
500 ms and signals below 380 m/z were electronically sup-
pressed. The three strongest doubly and triply charged ions
with intensities over 40 counts were selected for CID using
nitrogen, and MS/MS accumulation from 90-1800 m/z was
performed for 1 s per peptide. The precursor ion was excluded
for 200 s.
As a preliminary comparison at the level of 2D LC/MS/MS
analysis, ∼50 µg of the tryptic digests from FFPE and frozen
tissue extracts was ﬁrst fractionated by strong cation exchange
chromatography followed by reverse phase nano-HPLC/MS/
MS analysis. The separation column was Polysulfethyl A (150
× 1.0 mm, 5 µm, PolyLC). Samples were fractionated using a
two buffer system: SCX1 (10 mM KH2PO4, pH3) and SCX2 (10
mM KH2PO4, 500 mM KCl, pH3) employing a linear gradient
from 0% SCX2 to 40% SCX2 in 40 min with 20 fractions
collected. Each fraction was then analyzed in 3 separate
injections by nano-HPLC/MS/MS analysis as described above.
The 1D LC/MS/MS data was extracted (Analyst ver. r2.0,
Mascot ver. b21, Applied Biosystems) and submitted to the
Mascot server using Mascot Daemon (ver. 2.2, Matrix Science,
Figure 1. Summary of optimized surfactant/heat-based protein
extraction protocol for formalin-ﬁxed, parafﬁn-embedded tissue
blocks.
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to human entries (208 155 entries, 04.09.2009) using the fol-
lowing parameters: enzyme, trypsin; missed cleavages, 1;
variable modiﬁcations, methionine oxidation and carbami-
domethylation; peptide charge, 2+ and 3+; peptide tolerance,
0.15 Da; MSMS tolerance, 0.10 Da. In all probabilistic database
searches, proteins with a minimum of 2 signiﬁcant peptide(s)
(p < 0.05) were considered identiﬁed. The false positive rate
was 2.29% determined by selecting the decoy option of the
Mascot search. The 2D LC/MS/MS data was analyzed by
Protein Pilot (v1, Applied Biosystems) using the same database
and the same parameters as the Mascot search. Proteins from
multiple injection analysis were automatically grouped to
eliminate the redundancy. The false positive rate was estimated
at 3.31% using the decoyed database generated by Emboss (ver.
6.2.0).
NanoAcquity UPLC, LC-MSE and Label-Free Quantita-
tive Analyses. A nanoAcquity UPLC system operating in
trapping mode was used to separate peptides and introduce
the samples to the mass spectrometer. The trapping column
(180 µm i.d. × 20 mm) contained Symmetry C18 5 µm material
with trapping performed at 15 µL/min for 1 min using 100%
solvent A (aqueous 0.1% formic acid). The BEH130 C18 1.7 µm
analytical column (75 µm i.d. × 200 mm) was operated at a
ﬂow rate of 300 nL/min with a linear gradient from 1 to 40%
solvent B (ACN, 0.1% formic acid) over 90 min.
While preliminary optimization and qualitative validation of
the Rapigest protocol was carried out using an ABI Qstar mass
spectrometer, the quantitative validation of the extraction
methodology and its technical reproducibility were carried out
on a Waters Synapt HDMS system operating in the “V” mode
with a resolution of 10 000 fwhm. The system was operated in
LC-MSe mode where alternate scans are performed throughout
the LC separation, one at low collision energy to provide
peptide precursor mass information and the next at an elevated
collision energy to produce fragments. Lock mass reference
scans were acquired every 60 s. Each of the samples was run
in triplicate with blank injections between each set to ensure
minimal carryover. Vacuum-dried protein digests were resus-
pended in 10% (v/v) ACN to stock concentrations of 1 µg/µL
and were used as internal standards. For routine injection, the
sample was diluted 10-fold in 50 mM NH4HCO3 and an internal
standard of yeast alchohol dehydrogenase (ADH) was spiked
into the injection solution for a ﬁnal concentration of 10 fmol/
µL( 4µL of sample was injected on column containing 400 ng
of protein extract and 40 fmol of yeast alcohol dehydrogenase).
In addition, two-dimensional chromatography using reversed
phase-reversed phase at differential pH coupled with LC-MSE
was also used for the analysis of extracted FFPE and frozen
tissue as a preliminary examination of the increase in protein
identiﬁcations. The 2D separation was performed using RP
chromatography on a 150 µm × 5 cm XBridge C18 (5 µm)
column with a discontinuous step gradient at high pH in the
ﬁrst dimension, followed by a low pH gradient separation on
a7 5µm × 15 cm BEH C18 (1.7 µm) column in the second
dimension. To maximize sample recovery, an aqueous ﬂow was
mixed with the eluted organic-containing fractions prior to
trapping on the second-dimension trap column. The released
peptides were analyzed in both a 5 stage and 10 stage
separation loading 2.4 and 4.8 µg of total protein, respectively.
Each separation was processed separately, to create a monoiso-
topic peak list of all the eluting peptides and their associated
fragment ions, and these were subsequently merged prior to
database searching with Protein Lynx Global Server (PLGS 2.4)
against a nonredundant and randomized database.
The quantitation method was based on areas of the decon-
voluted chromatographic and mass spectral peaks for peptide
precursor-ions across injections and between samples. This was
analyzed automatically using the PLGS v2.4 informatics package
(Waters, U.K.).
8,9 The approach compares two or more experi-
ments by deﬁning the normalized mass spectrometric signal
intensity for any and all given peptides, as determined from
the LC-MSE experiment as a measure of their respective
amounts in the sample. In addition, concentrations of the
proteins in the sample (expressed in nanograms or femtomole
equivalents) were determined by referencing the average ion
intensity of the three best ionizing peptides for each protein
to those of the known concentration internal standard spike,
as has been previously described in detail.
26
Protein identiﬁcation was performed by database searching
using a previously published algorithm contained within the
PLGS software.
27 The data was searched against a Uniprot
Human database (version 14.6) with a 1× reverse sequence
database appended. In brief, time-aligned precursor ions and
their associated fragment ions were deconvoluted and deiso-
toped and then searched against the databank with 10 and 20
ppm tolerances for the peptide and their fragments, respec-
tively. For positive acceptance of a protein, the following
needed to be met: three fragment ions matched per peptide,
seven fragment ions per protein with at least one unique
peptide sequence per protein. The protein false discovery rate
(FDR) was set to 4% such that protein hits were returned until
the 4% of the total protein hits returned were random. A further
requirement placed upon the protein level results was that
protein sequences were needed to replicate in at least two of
three replicate injections, and as such, this took the protein
FDR to below 1%.
Statistical Analysis. Reproducibility in the quantitation for
proteins common to all biological and technical replicates was
assessed using the coefﬁcient of variation expressed as a
percentage. Spearman’s rank correlation was used to assess the
association between quantitation (expressed as a fold-change
between tumor and normal tissue) in frozen and FFPE tissue
extracts.
Results
Protocol Optimization. Initial method optimization experi-
ments directly comparing buffers and reproducibility in fresh-
frozen and FFPE samples showed that maximum extraction
efﬁciency as assessed by numbers of proteins identiﬁed and
sequence coverage was consistently achieved with the RapiGest
buffer protocol, followed by the ACN-NH4HCO3 buffer in both
1D and 2DLC-MS/MS analyses (data not shown). SELDI-TOF
analyses of other buffers studied failed to produce data
comparable to RapiGest and ACN-NH4HCO3. A preliminary
comparison of the latter two buffers using SELDI-TOF as a
screening platform in postextraction (protein) and postdiges-
tion extracts (peptides) is shown in Figure 2, clearly illustrating
the enhanced tryptic digestion in Rapigest as reported previ-
ously.
24 The optimum RapiGest concentration was selected as
0.2% (w/v) in 50 mM NH4HCO3 as informed by titration
experiments (data not shown). Routine extractions from FFPE
blocks (3 × 10 µm thick slices, 5 × 5 mm each) in 100 µL
extraction buffer volumes yielded total protein concentrations
of 1.36 ( 0.60 µg/µL( n ) 8). Extracted total protein concentra-
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tissue volume (1.08 + 0.25 µg/µL; n ) 8, p ) 0.17).
Comparison of Extraction of Frozen and FFPE Tissue
Extracts. Initial experiments using 8 samples from 2 patients
(matched normal/tumor and FFPE/frozen) were carried out
comparing extraction efﬁcacies by 1D-LC-MS/MS using the
QSTAR mass spectrometer. Following this, one set of four
samples were further analyzed using the Waters Synapt HDMS
quadruple-oa-Tof mass spectrometer. Triplicate samples of
fresh and FFPE extracts spiked with an internal standard to
normalize protein loading between experiments were analyzed
in LC-MSe mode in a 1D-UPLC-HDMS experiment and
proteins replicating in at least two out of three injections for
each sample were determined and used for the comparative
analysis (Supplementary Data 1). A total of 283 proteins were
identiﬁed from the normal renal tissue FFPE extract compared
with 268 from the matched fresh-frozen extract. A total of 350
unique protein were identiﬁed; of these, 201 (70-75% of each
data set and 58% of total proteins identiﬁed) were common to
both extracts with 82 (23%) proteins being unique to the FFPE
data and a further 67 (19%) proteins identiﬁed only in the fresh
normal tissue extract (Figure 3a). Analysis of the matched tumor
samples showed similar results (Figure 3b). An analysis of the
subcellular localization pattern of individual proteins in this
data set derived using the Ingenuity Systems pathway analysis
software (Ingenuity Systems, Inc., version 8.0) shows broadly
similar distributions of proteins in the cellular compartments
(Figure 4) irrespective of whether they were form frozen or
FFPE extracts.
Assessing Technical Reproducibility of the RapiGest
Extraction Method. In each of the technical replicates (i.e.,
independently prepared and analyzed extracts TR1 to TR4),
Figure 2. Comparison of representative protein extraction efﬁciencies for FFPE normal renal tissues with Rapigest and ACN-NH3HCO3
buffers using SELDI-TOF (Ciphergen). Spectral acquisition was carried out on 1 µg protein extracts spotted on NP20 chips. (a) The
postextraction protein spectra and (b) the post-tryptic digestion peptide spectra for the two extraction buffers.
Figure 3. Representative example of a comparison of protein
extracts (400 ng) from frozen and FFPE extracts in (a) normal
renal cortical tissue and (b) RCC tissue, analyzed using a
NanoAcquity 1D-UPLC-HDMS quadrupole-oa-Tof (Waters U.K.).
Each extract was run in triplicate and proteins appearing in at
least 2 of three replicates were included in the analysis.
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in at least 2 out of the three determinations, that is, (254/383)
) 66%, 63%, 65%, and 61.5% of the total number of proteins
across all injections (Figure 5a). Similar results were also
obtained using the QSTAR in this and one further sample (data
not shown). A comparative analysis of the 4 data sets showed
191 proteins conserved across all four technical replicate data
sets (i.e., (191/254) ) 75.2% of TR1, 73.7% of TR2, 70.2% of
TR3, 77.6% of TR4), showing reproducible qualitative and
quantitative metrics at the protein and peptide level (Supple-
mentary Data 2). The overall analysis of protein overlap
between the 4 replicates is shown in Figure 5b.
Absolute quantitation amounts could be determined for 150
proteins common to all replicates. The average CV (%) of
nanograms amounts calculated on column were determined
as 19.1% for TR1, 18.4% for TR2, 18.3% for TR3, and 20.5% for
TR4. Combining all technical replicates, the average CV for
nanograms amount on column was 28.8%. The reproducibility
of quantitation and the stringency of isoform assignment is
illustrated in Figure 6 for two selected proteins: fructose
biphosphate aldolase (A-muscle, B-liver and C-brain types) and
lactate dehydrogenase (A-muscle, B-heart, and C-testis sub-
units).
Comparing Fresh and FFPE Extraction Using 2D LC-MS-
MS. Preliminary 2D-LC-MS-MS experiments to compare over-
lap in identiﬁed proteins between the fresh and FFPE extracts
from matched normal and tumor were carried out using the
Applied Biosystems QSTAR XL quadrupole TOF hybrid mass
spectrometer as detailed in the Eperimental Procedure section.
Fresh frozen and FFPE extract from matched tumor tissue
yielded 490 and 477 proteins, respectively (Supplementary Data
3). However, only 234, that is, approximately 50% of the
proteins in each set, were common to both, with a total of 678
unique proteins overall. Data from normal frozen and FFPE
tissue identiﬁed 622 and 490 proteins, respectively, with 305
(i.e., 50-60% of each set) being common to both and a total
of 807 unique proteins.. Further, 2D experiments comparing
expansion in proﬁling capabilities to 1D analysis were carried
out using 2D-UPLC-MSE on the Waters Synapt HDMS quad-
rupole-oa-Tof mass spectrometer and are detailed below.
Comparing 1D versus 2D LC-MS/MS. Reverse phase (RP)
and multidimensional (RP-RP) LC-MS/MS separations of FFPE
extracts from two samples, matched tumor and normal renal
tissue, were directly compared to provide a preliminary as-
sessment of the expansion in protein proﬁling capabilities with
increasing multidimensionality. For the 2D data processing,
merging of individual fractions and searching showed an
increase in number of proteins identiﬁed from approximately
250 (2/3) typically in a 1D experiments to >450 proteins in 2D
5 step experiments. With more separation steps, an increased
number of low-abundance species were reproducibly sampled
due to the reduced interference from highly abundant species.
The increase in protein identiﬁcations can be correlated to the
Figure 4. Subcellular localization analyses (Ingenuity IPA software
(version 8.0)) of the proteins identiﬁed from matched normal
renal cortex and RCC tissue extract (FFPE and frozen tissue;
Figure 3) using the optimized Rapigest surfactant protocol. The
proteins were identiﬁed at high conﬁdence using a NanoAcquity
UPLC-HDMS quadrupole-oa.Tof with protein loading normalized
using a spiked external standard.
Figure 5. Technical replicate analysis of FFPE normal renal tissue
extracts. (a) Proteins identiﬁed at high stringency across triplicate
injections (1, 2, 3; 400 ng each injection) of each of 4 indepen-
dently extracted replicates (TR1, TR2, TR3, TR4) from a single
normal renal cortex FFPE tissue block; (b) shows the overall
distribution patterns of the proteins within the replicate sets
analyzed by 1D-LC-MS/MS. A total of 191 proteins were com-
mon to all four replicates with TR1, TR2, TR3 and TR4 extracts
having 254, 259, 272, and 246 proteins identiﬁed, respectively,
at high stringency.
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increases in direct proportion to the number of ﬁrst-dimension
fractions, or steps, that are used, with the optimum load of
protein being approximately 500 ng for each ﬁrst-dimension
step. An expansion in peptide numbers and sequence coverage
was observed which correlates to the increased protein load
on column between the single and two-dimensional separation
approaches (data not shown). A comparison of the overall
expansion of the number of proteins identiﬁed in normal and
tumor FFPE extracts using 1D and 2D approaches is sum-
marized in Figure 7 (Supplementary Data 4). For normal FFPE
tissue extracts, 284 proteins were identiﬁed at high conﬁdence
(2/3) in triplicate injection 1D-UPLC-MSE runs and 505 proteins
were identiﬁed using a 5 step 2D-UPLC-MSE. For tumor
samples, 236 proteins (2/3) were identiﬁed in the 1D run and
an expansion to 699 proteins observed with 2D-UPLC-MSE. The
total number of proteins identiﬁed in the 1D triplicate injec-
tions was 418 for the normal and 370 for the tumor.
Preliminary Comparative Analysis of Differential Expres-
sion in Frozen/FFPE RCC Tissue Extracts by 1D LC-MS/
MS. Absolute label-free quantitation utilizing the intensity of
the top three peptides from a yeast alchohol dehydrogenase
internal standard was used to compare the four samples to
assess tumor-normal differential expression proﬁles for the
FFPE and frozen tissue extracts from a single patient. All
samples were run in triplicate and tumor/normal expression
ratios were based on the averaged concentrations of individual
proteins in comparison with the internal standard (Supple-
mentary Data 1). All protein concentrations less than 1 fmol
were given an arbitrary value of 1 for the calculation of normal/
tumor fold changes. Fold changes plotted for a total of 205
proteins in each data set are shown in Figure 8. The Spearman
Figure 6. Quantitative analysis of reproducibility of isoform assignment in a series of 4 technical replicates from normal renal cortical
FFPE extracts. PLGS scores for the replicates are shown for two selected protein examples, (a) aldolase A, B, C and (b) LDH A, B and
C. The quantitation shows averaged PLGS scores from triplicate injections for each protein compared in the 4 technical replicates with
standard deviations for the replicate series.
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signiﬁcant moderately strong positive correlation.
Speciﬁc examples of proteins which we and others have
previously reported as being differentially expressed in RCC
tissue
27-29 were examined in these results as a preliminary
validation of the overall method (Figure 9). Normal/tumor
differential expression patterns previously seen and described
here in frozen tissue were also maintained in FFPE tissue
extracts, further validating the approach.
Discussion
Current tissue-based proteomic applications, while offering
a realistic chance of yielding novel markers, are limited by
problems in procuring adequate numbers of tissue samples in
its optimum fresh or frozen form, particularly for less common
diseases or subtypes.
1,2 Annotated archival tissue banks con-
stitute an untapped resource for biomarker-driven investiga-
tions,
16,18,21,30 particularly in the validation phase when large
sample cohorts are required. However, covalent formalin-
induced modiﬁcations in proteins impair immune-reactivity
and extraction, making FFPE tissues largely intractable for
proteomic analyses.
30,31 The potential implications of harness-
ing this vast alternate tissue resource has, more recently,
triggered a keen research focus on developing detergent-based,
heat-induced cross-link reversal strategies to permit effective
protein extraction for proteomic applications.
4,6,7,21,32,33 Al-
though still in its infancy, a notable bottleneck in the whole
exercise continues to be the lack of a high-throughput extrac-
tion methodology which is reproducibly quantitative and cost-
effective. Such an option is critical if the method is to be useful
in harnessing the potential of the archival proteome for large-
scale biomarker discovery and validation research. Reproduc-
ible quantitative metrics will enable the comparison and
reﬁnement of published extraction protocols in this early phase
of method development. More importantly, it would allow the
quantitative evaluation of a range of preanalytical variables in
FFPE extracts (e.g., age of blocks, ﬁxation methods, duration
of ﬁxation, etc.) that could potentially interfere with data
interpretation, permitting the objective assessment of the
usefulness of the vast archival resources.
The surfactant/heat-based extraction methodology reported
in the paper offers a cost-effective, user-friendly, single tube
protein extraction option for FFPE tissue. Its compatibility with
high-throughput mass spectrometry and label-free quantitation
make it a powerful tool to begin to further quantitatively
explore the archival tissue proteome. A systematic review of
detergent options identiﬁed the SDS substitute RapiGest as the
most effective extraction buffer for archival tissue proteomics.
The surfactant was selected on the basis of its suitability for
mass spectrometry and trypsin digestion, its heat resistance,
and strong detergent/denaturant properties. The increased
protein extraction observed is in part attributable to the
enhancement of trypsin digestion by the RapiGest buffer and
its compatibility with HPLC and MS, obviating the need for
detergent cleanup and the sample loss thereby incurred.
Protein extraction and identiﬁcation comparable to matched
fresh frozen tissue extracts were achieved reproducibly, mir-
Figure 7. Comparison of the expansion in proteins identiﬁed
between 1D (400 ng protein) and 2D LC-MS/MS (2 µg) experi-
ments on normal renal and RCC FFPE extracts using the Nano-
Acquity UPLC-HDMS quadrupole-oa Tof (Waters, U.K.).
Figure 8. Comparison of normal/RCC tumor protein expression
ratios (positive values ) higher in tumor, negative ) higher in
normal tissue) derived from the label-free quantitative analyses
of frozen versus FFPE tissue extracts (205 proteins in total). (a)
All proteins plotted; (b) zoomed-in version of graph showing the
region between 50:1 and 1:50.
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Liquid Tissue buffer protocols for 1D LC-MS analysis.
15,17 Total
protein yields from FFPE and frozen blocks were comparable
(and similar to values from the Liquid Tissue and ammonium
bicarbonate sonication protocols).
8,15 Percentage overlap be-
tween frozen and FFPE protein identiﬁcations were 58%
(normal renal extract) and 57% (RCC tumor extract) of total
proteins identiﬁed in our study, which is comparable with
57-67% in published results when similar search parameters
were used.
8 In preliminary experiments using the 2D approach,
only 50-60% of proteins in each FFPE and frozen tissue data
set were common representing only 35-37% of total proteins
identiﬁed. This highlights the challenges faced particularly with
regard to reproducibility of detection of the lower abundance
proteins when these types of analyses are extended through
further fractionation steps.
Compared to the current leader methodologies that use an
MS platform to mine the archival proteome, the RapiGest
surfactant protocol, while exhibiting equivalence in protein
inventories, has the signiﬁcant advantage of being a low cost,
easy to use quantitative option for suitable for application to
large sample cohorts. The slightly higher proportion of proteins
identiﬁed in our FFPE extract when compared to frozen extract
could be attributed to the use of OCT embedded tissue blocks
and the possible interference with LC-MS analysis of the OCT
tissue embedding medium.
5,15 Preliminary analysis of FFPE
extracts shows proteins with a broad range of molecular
functions from all subcellular compartments, including mem-
brane proteins. Analysis of technical reproducibility in 4 parallel
separate FFPE extracts from the same tissue block, each
injected as a triplicate, showed preservation of 70.2 - 77.6%
of the total number of proteins across all injections.
The lack of studies using quantitative methodology in current
published literature makes it difﬁcult to compare our protocol
with other published protocols, highlighting the relevance of
such protocols in the early phase of method development. A
similar argument can be applied to lack of adherence to
standard criteria for publishing proteomic data in many
published papers. The resulting variation in protein numbers
attributed to different methodologies pose signiﬁcant chal-
lenges for method comparison and protocol reﬁnement. In a
detailed study investigating the equivalence of protein inven-
tories across FFPE and frozen samples, Sprung et al. report a
yield of ∼400 conﬁdent protein identities from 200 µg total
protein extract in FFPE tissue, reporting 90% protein equiva-
lence both in numbers of proteins identiﬁed and in identities
of the protein inventories.
8 Our 1D-LC-MS approach yielded
∼235-285 proteins from a considerable smaller protein quan-
tity of 500 ng. The lower number could be attributed to the
use of high stringency 2/3 selection criteria from the 3 replicate
runs. Total unique protein numbers identiﬁed across all three
replicates in the experiments were ∼418 for normal and 370
for the tumor sample. Comparable approaches with the Liquid
Tissue proprietary buffer identiﬁed ∼179 proteins from FFPE
liver extracts.
15
Label-free quantitative approaches are becoming increas-
ingly popular in mass spectrometry and informatics due to their
ability to overcome limitations associated with other labeling
techniques like cost, complexity, and time. In addition, there
is in principle essentially no limit to the number of experiments
that can be compared. In experiments designed to evaluate the
label-free quantitation strategy, differential expression proﬁles
for the data sets studied showed comparable expression
patterns between fresh and FFPE normal/tumor pairs with a
statistically signiﬁcant preservation in directional regulation for
most proteins. Of the proteins that failed to follow this pattern,
a signiﬁcant proportion constituted cytoskeleton derived pro-
teins (e.g., alpha actinin, tropomyosin alpha 4 chain, cyto-
keratin 18, tubulin alpha 18, myosin light polypeptide 6, tubulin
alpha 3 chain, and myosin 9 heavy chain). Further work needs
to be done to ascertain if this observation is attributable to an
artifact of processing. Furthermore, a modest disparity was also
observed in a group of membrane proteins (e.g., moesin, amine
oxidase, and peroxiredoxin 5 mitochondrial precursor), cor-
roborating previous reports of aggregation and poor extraction
of some membrane proteins when using extended heat pro-
tocols.
7 The study also identiﬁed a range of previously validated
renal cell carcinoma tissue markers from both FFPE and frozen
extracts (e.g., vimentin, annexin 4, GFAP, FABP7, HSP27,
gamma enolase, superoxide dismutase, etc.).
27-29
Archival proteomics is still in its infancy and continuous
method development to increase depth of tissue mining,
sequence coverage, and reliable quantitation is essential.
Critical to advancing such studies further are the more detailed
examination of its technical use in a larger-scale biomarker
discovery experiment with extensive validation of ﬁndings, for
example, by immunohistochemistry or Western blotting. Fur-
Figure 9. Quantitative comparison of normal and tumor expres-
sion of several previously described proteins shown to be
differentially expressed
27-29 in (a) fresh and (b) FFPE tissue
extracts. Ratios calculated from deduced concentrations with
reference to an internal standard in femtomoles/400 ng protein
load using 1D-LC-MS are averaged from 3 injections and
presented with their respective standard deviations.
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of a range of preanalytic variables associated with tissue
collection, processing, and storage (including surgical ischemia,
processing protocols, ﬁxatives and ﬁxation length, and length
of storage) that could potentially confound data interpretation
need to be quantitatively deﬁned. The label-free surfactant
based extraction strategy presented in this paper constitutes a
powerful and necessary tool to initiate the objective assessment
of this alternate tissue resource and harness the signiﬁcant
opportunities made available by the maturation of proteomic
technologies.
Conclusions
The potential contribution of the vast formalin-ﬁxed archival
collections to the biomarker discovery and validation initiative
cannot be underestimated, particularly in rarer diseases where
the acquisition of tissue in its optimal fresh frozen form is
increasingly challenging. We report the initial development and
validation of an efﬁcient, cost-effective, quantitative extraction
methodology permitting the quantitative analysis of archival
tissues. Further studies will investigate the variation induced
as a consequence of the ﬁxation and storage process and will
employ the method in a full-scale comparative biomarker
discovery project, but at this stage, only at the 1D LC fraction-
ation level to fully explore its potential.
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